Association of Serum Leptin and Adiponectin Levels with Blood Pressure and Insulin Resistance in Obese Adults: A Cross-Sectional Study
Adipokine Imbalance in Obese Adults
DOI:
https://doi.org/10.69750/dmls.02.06.0129Keywords:
Leptin, Adiponectin, Obesity, Hypertension, Insulin resistanceAbstract
Background: Obesity is widely recognized as a serious worldwide health issue, with a clear relationship to metabolic abnormalities including insulin resistance and high blood pressure. Leptin and adiponectin, two adipose-derived hormones, serve conflicting roles in regulating vascular and metabolic activities. However, few studies have looked at their link with cardiometabolic risk in South Asian populations. The purpose of this research was to look at how serum leptin and adiponectin affect blood pressure and insulin resistance in obese Pakistani adults.
Methods: A cross-sectional research was carried out at three tertiary care facilities from January 2024 to June 2025. A total of 120 obese people (BMI ≥30 kg/m²; ages 25-60) were recruited. Demographic, anthropometric, and clinical data were gathered. Blood pressure was assessed using established methods, and fasting blood samples were tested for glucose, insulin, leptin, and adiponectin. Insulin resistance was evaluated using the homeostasis model assessment (HOMA-IR). Correlation tests and multivariate regression were used in the statistical analysis, which controlled for age, gender, and BMI.
Results: The study population's mean BMI was 33.8 ± 3.9 kg/m2, and its mean age was 44.5 ± 9.8 years, with 57.5% of the participants being female. The mean values of leptin and adiponectin were 21.5 ± 9.3 ng/mL and 6.2 ± 2.1 µg/mL, respectively. When compared to those with normotension, hypertensive participants showed considerably greater levels of leptin (25.2 ± 8.7 vs. 18.3 ± 7.2 ng/mL, p<0.01) and significantly lower levels of adiponectin (5.1 ± 1.8 vs. 7.2 ± 2.3 µg/mL, p<0.01). Systolic pressure and HOMA-IR were favorably connected with leptin (r=0.38 and r=0.42, p<0.001), but adiponectin was inversely correlated (r=–0.32 and r=–0.39, p<0.01). Both adiponectin and leptin were validated by regression models as independent predictors of insulin resistance and hypertension.
Conclusion: Obese Adults from Pakistan show a clear imbalance between leptin and adiponectin, with greater levels of leptin and lower levels of adiponectin being independently associated with insulin resistance and high blood pressure. These adipokines might guide preventative and intervention plans and act as early markers of cardiometabolic risk.
Downloads
References
Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Nutrients. 2019;11(2):454. DOI: 10.3390/nu11020454
Ayina CN, Noubiap JJ, Pefura-Yone EW, et al. Leptin-to-adiponectin ratio and metabolic syndrome in a Cameroonian population: A cross-sectional study. Lipids Health Dis. 2017;16:26. DOI: 10.1186/s12944-017-0440-7
Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T. Adiponectin/adiponectin receptor in disease and aging. NPJ Aging Mech Dis. 2017;3:17. DOI: 10.1038/s41514-017-0017-9
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2017;17(5):325–38. DOI: 10.1038/nri.2017.45
Gilardini L, Croci M, Bertoli S, et al. Adiponectin/leptin ratio as a predictor of visceral fat and dysmetabolism. J Endocrinol Invest. 2017;40(1):79–87. DOI: 10.1007/s40618-016-0608-6
Liu L, Wang Z, Xu C, Zhang J, Zhang X. Associations of adipokines with blood pressure and hypertension in Chinese adults: A cross-sectional study. Clin Chim Acta. 2021;515:136–42. DOI: 10.1016/j.cca.2021.05.008
Koh YLE, Chew WS, Chua J, et al. Association of adiponectin, leptin, and their ratio with insulin resistance and type 2 diabetes among Asians. J Diabetes Investig. 2023;14(3):419–26. DOI: 10.1111/jdi.13871
Min KJ, Lee JT, Joe Y, et al. Adiponectin alleviates hypertension through regulation of endothelial nitric oxide synthase. Korean J Physiol Pharmacol. 2022;26(5):375–82. DOI: 10.4196/kjpp.2022.26.5.375
Blüher M. Adipokines Removing roadblocks to obesity and diabetes therapy. Mol Metab. 2019;24:1–2. DOI: 10.1016/j.molmet.2019.02.005
Hansson B, Säll J, Åberg M, et al. Leptin and risk of hypertension Results from the Malmö Diet and Cancer Study. Hypertension. 2019;74(2):319–26. DOI: 10.1161/HYPERTENSIONAHA.119.12804
Cui X, Zhao Q, Zhou X, et al. Serum leptin and adiponectin levels are independently associated with metabolic syndrome in Chinese adults. Clin Chim Acta. 2020;504:78–84. DOI: 10.1016/j.cca.2020.01.033
Khadir A, Kavalakatt S, Madiraju SRM, et al. Leptin and adiponectin signaling in obese patients with type 2 diabetes: A cross-sectional study. Front Endocrinol (Lausanne). 2018;9:638. DOI: 10.3389/fendo.2018.00638
Choi KM, Lee J, Hong H, et al. Leptin/adiponectin ratio as a predictive marker of insulin resistance in Korean children and adolescents. Diabetes Metab J. 2018;42(6):498–509. DOI: 10.4093/dmj.2018.0049
Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Sci Transl Med. 2019;11(510):eaax7594. DOI: 10.1126/scitranslmed.aax7594
de Mello VD, Schwab U, Kolehmainen M, et al. Leptin and adiponectin levels are independently associated with risk of insulin resistance in healthy adults. Diabetologia. 2020;63(2):295–305. DOI: 10.1007/s00125-019-05073-0
Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2021;128(11):1477–95. DOI: 10.1161/CIRCRESAHA.120.318365
Younis A, Fayed HM, Abd-Elaziz MA, Soliman NM. Role of leptin-to-adiponectin ratio as a predictor of metabolic syndrome in Egyptian obese adolescents. J Pediatr Endocrinol Metab. 2018;31(10):1111–7. DOI: 10.1515/jpem-2018-0233
Rajpathak SN, Wylie-Rosett J, Gunter MJ, et al. Biomarkers of adiposity and cardiovascular disease risk in South Asians: A review of recent data. Int J Obes (Lond). 2019;43(1):74–82. DOI: 10.1038/s41366-018-0143-y
Park H, Park Y, Cho GJ, et al. Adiponectin as a biomarker for insulin resistance: A large-scale cross-sectional study. Ann Lab Med. 2018;38(2):109–15. DOI: 10.3343/alm.2018.38.2.109
Lechleitner M, Kucera E, Kopp HP, et al. Adiponectin/leptin ratio: A useful marker for metabolic syndrome in children. Acta Diabetol. 2018;55(7):701–10. DOI: 10.1007/s00592-018-1138-3
Evagelopoulos R, Korlach U, Köstler J, et al. Leptin/adiponectin ratio correlates with insulin resistance in morbidly obese subjects. Eur J Clin Invest. 2018;48(6):e12927. DOI: 10.1111/eci.12927
Henry S, Qadri F, O’Reilly MW, et al. Leptin and hypertension: Mechanisms and clinical implications. Hypertens Res. 2020;43(11):1119–28. DOI: 10.1038/s41440-020-00481-4
Peyrou M, Ferré P, Foufelle F. Leptin receptor expression and signaling in adipose tissue. J Clin Endocrinol Metab. 2019;104(1):6–15. DOI: 10.1210/jc.2018-01234
Na T, Wang X, Wang S, et al. Serum adiponectin and its predictive value in insulin sensitivity among adults. PLoS One. 2021;16(3):e0247665. DOI: 10.1371/journal.pone.0247665
Fang H, Judd RL. Adiponectin regulation and function. Clin Chim Acta. 2022;524:70–80. DOI: 10.1016/j.cca.2021.11.008
Zhang Y, Wang Y, Shi W, et al. Association of the adiponectin-leptin ratio with risk of metabolic syndrome and prediabetes in a Chinese adult population. BMC Endocr Disord. 2023;23(1):45. DOI: 10.1186/s12902-023-01267-3
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
